RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas

NCT01198665 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cell Lymphoma Unspecified
Anaplastic Large Cell Lymphoma, ALK-negative
Angioimmunoblastic T Cell Lymphoma
Cutaneous T Cell Lymphoma

Interventions

DRUG: RAD001 (Everolimus)

Sponsor

Samsung Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]